UY25818A - Modificacion cristalina b del acido 8-ciano-1-ciclopropil-7- (1s,6s-2,8-diazabiciclo[4.3.0]-nonan-8-il)-6-fluor-1,4-dihidro-4-oxo-3-quinolincarboxilico - Google Patents

Modificacion cristalina b del acido 8-ciano-1-ciclopropil-7- (1s,6s-2,8-diazabiciclo[4.3.0]-nonan-8-il)-6-fluor-1,4-dihidro-4-oxo-3-quinolincarboxilico

Info

Publication number
UY25818A
UY25818A UY0001025818A UY25818A UY25818A UY 25818 A UY25818 A UY 25818A UY 0001025818 A UY0001025818 A UY 0001025818A UY 25818 A UY25818 A UY 25818A UY 25818 A UY25818 A UY 25818A
Authority
UY
Uruguay
Prior art keywords
nonan
oxo
crystalline modification
quinolincarboxilico
ciclopropil
Prior art date
Application number
UY0001025818A
Other languages
English (en)
Inventor
Himmler Thomas
Rast Hubert
Hallenbach Werner
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of UY25818A publication Critical patent/UY25818A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invención se refiere a una modificación cristalina del ácido 8 - ciano - 1 - ciclopropil - 7 - (1S, 6S - 2, 8 - diazabiciclo [4.3.0] nonan - 8 - il) - 6 - fúor - 1, 4 - dihidro - 4 - oxo - 3 quinolincarboxílico de la fórmula (I), a procedimientos para su obtención así como a su empleo en preparaciones farmacéuticas. La modificación cristalina puede diferenciarse de las otras modificaciones cristalinas del ácido 8 - ciano - 1 - ciclopropil - 7 - (1S, 6S - 2, 8 - diazabiciclo [4.3.0] nonan - 8 - il) - 6 - fúor - 1, 4 - dihidro - 4 - oxo - 3 quinolincarboxílico de la fórmula (I) por medio de su diagrama de difracción de polvo a los rayos X característico y de su diagrama de análisis térmico diferencial Procedimiento para la obtención de la modificación B, caracterizado porque cuando se utiliza etanol como disolvente, se emplean metil-pirrolidina, dimetilformamida o sulfolano a modo de otros disolventes; tambièn se emplean como bases trimetilamina, trietilamina o etil-diisopropilamina; cuando se emplea etanol como disolvente se utiliza N-metil-pirrolidona
UY0001025818A 1998-11-25 1999-11-25 Modificacion cristalina b del acido 8-ciano-1-ciclopropil-7- (1s,6s-2,8-diazabiciclo[4.3.0]-nonan-8-il)-6-fluor-1,4-dihidro-4-oxo-3-quinolincarboxilico UY25818A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19854355A DE19854355A1 (de) 1998-11-25 1998-11-25 Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure

Publications (1)

Publication Number Publication Date
UY25818A true UY25818A (es) 2016-06-30

Family

ID=7888959

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001025818A UY25818A (es) 1998-11-25 1999-11-25 Modificacion cristalina b del acido 8-ciano-1-ciclopropil-7- (1s,6s-2,8-diazabiciclo[4.3.0]-nonan-8-il)-6-fluor-1,4-dihidro-4-oxo-3-quinolincarboxilico

Country Status (29)

Country Link
US (1) US6664268B1 (es)
EP (1) EP1133497B1 (es)
JP (2) JP5127094B2 (es)
KR (1) KR100740950B1 (es)
CN (1) CN1150193C (es)
AR (1) AR028467A1 (es)
AT (1) ATE289606T1 (es)
AU (1) AU767890B2 (es)
BR (1) BRPI9915682B8 (es)
CA (1) CA2351707C (es)
CZ (1) CZ300012B6 (es)
DE (2) DE19854355A1 (es)
DK (1) DK1133497T3 (es)
ES (1) ES2237186T3 (es)
HK (1) HK1042705B (es)
HU (1) HU229071B1 (es)
IL (2) IL142695A0 (es)
NO (1) NO318065B1 (es)
NZ (1) NZ511862A (es)
PL (1) PL196078B1 (es)
PT (1) PT1133497E (es)
RU (1) RU2248355C2 (es)
SK (1) SK285554B6 (es)
TR (1) TR200101444T2 (es)
TW (1) TWI245767B (es)
UA (1) UA67873C2 (es)
UY (1) UY25818A (es)
WO (1) WO2000031076A1 (es)
ZA (1) ZA200103187B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19854356A1 (de) 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19908449A1 (de) 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure
DE19908448A1 (de) 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation D von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo[4.3.0)nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino incarbonsäure
DE102004015981A1 (de) 2004-04-01 2005-10-20 Bayer Healthcare Ag Neue kirstalline Form von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
DE102006049520A1 (de) * 2006-10-20 2008-04-24 Bayer Healthcare Ag Verfahren zur Herstellung von Pradofloxacin
DE102007026550A1 (de) * 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
PE20191462A1 (es) 2017-02-13 2019-10-16 Bayer Animal Health Gmbh Composicion liquida que contiene pradofloxacina

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5036099A (en) * 1987-02-02 1991-07-30 Pfizer Inc. Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide
JP2676521B2 (ja) * 1988-03-22 1997-11-17 北陸製薬株式会社 キノロンカルボン酸化合物ｉ型結晶の製造法
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
JP2832848B2 (ja) * 1989-10-21 1998-12-09 株式会社林原生物化学研究所 結晶２―Ｏ―α―Ｄ―グルコピラノシル―Ｌ―アスコルビン酸とその製造方法並びに用途
BR9509688A (pt) 1994-11-18 1997-09-30 Upjohn Co Composto e composição farmacêutica
DE19546249A1 (de) * 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE19633805A1 (de) * 1996-02-23 1997-08-28 Bayer Ag Gegenenenfalls substituierte 8-Cyan-l-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäuren und ihre Derivate
NZ331468A (en) * 1996-02-23 2000-02-28 Bayer Ag Substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo-[4,3.0]-nonan-8-yl)-6-fluoro-1, 4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives
DE19649681A1 (de) * 1996-11-29 1998-06-04 Basf Ag Verfahren zur Herstellung eines kristallinen Feststoffes aus Glycin-N,N-diessigsäure-Derivaten mit hinreichend geringer Hygroskopizität
DE19854356A1 (de) 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19908448A1 (de) 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation D von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo[4.3.0)nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino incarbonsäure
DE19908449A1 (de) 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure

Also Published As

Publication number Publication date
PT1133497E (pt) 2005-07-29
IL142695A (en) 2006-04-10
HUP0104713A2 (hu) 2002-04-29
DK1133497T3 (da) 2005-05-17
SK285554B6 (sk) 2007-03-01
DE19854355A1 (de) 2000-05-31
RU2248355C2 (ru) 2005-03-20
HK1042705B (zh) 2005-03-11
KR100740950B1 (ko) 2007-07-19
KR20010080927A (ko) 2001-08-25
PL196078B1 (pl) 2007-12-31
EP1133497B1 (de) 2005-02-23
JP5127094B2 (ja) 2013-01-23
TWI245767B (en) 2005-12-21
HK1042705A1 (en) 2002-08-23
IL142695A0 (en) 2002-03-10
BR9915682A (pt) 2001-08-14
AR028467A1 (es) 2003-05-14
SK6832001A3 (en) 2001-12-03
AU767890B2 (en) 2003-11-27
CA2351707A1 (en) 2000-06-02
TR200101444T2 (tr) 2002-01-21
UA67873C2 (uk) 2004-07-15
CN1150193C (zh) 2004-05-19
ATE289606T1 (de) 2005-03-15
BRPI9915682B8 (pt) 2021-05-25
NZ511862A (en) 2003-08-29
CN1328556A (zh) 2001-12-26
NO20012461L (no) 2001-05-18
DE59911666D1 (de) 2005-03-31
ES2237186T3 (es) 2005-07-16
HU229071B1 (en) 2013-07-29
CZ20011857A3 (cs) 2001-09-12
WO2000031076A1 (de) 2000-06-02
NO20012461D0 (no) 2001-05-18
NO318065B1 (no) 2005-01-31
ZA200103187B (en) 2002-06-26
PL347785A1 (en) 2002-04-22
AU1651700A (en) 2000-06-13
CZ300012B6 (cs) 2009-01-14
JP2012236841A (ja) 2012-12-06
JP2002530407A (ja) 2002-09-17
BRPI9915682B1 (pt) 2017-02-21
HUP0104713A3 (en) 2002-12-28
US6664268B1 (en) 2003-12-16
CA2351707C (en) 2011-02-01
EP1133497A1 (de) 2001-09-19

Similar Documents

Publication Publication Date Title
ES2214434T3 (es) Forma cristalina alfa de la sal de terc-butilamina de perindopril.
UY25818A (es) Modificacion cristalina b del acido 8-ciano-1-ciclopropil-7- (1s,6s-2,8-diazabiciclo[4.3.0]-nonan-8-il)-6-fluor-1,4-dihidro-4-oxo-3-quinolincarboxilico
TR200102910T2 (tr) èeker artìklarìyla ikame edilmiç 1,4-benzotiyazepin-1,1-dioksid trevleri
NZ523957A (en) 6.alpha., 9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17-carbothioic acid S-fluoromethyl ester as an anti-inflammatory agent
TR200401029T4 (tr) Asilfenil-üre türevleri, imalat yöntemleri ve ilaç maddesi olarak kullanımları
IT1096916B (it) Derivati di acidi fenossi-fenil-tip-alcan-carbossilici,procedimento per la loro preparazione e loro impiego
DK1511732T3 (da) Fremgangsmåde til fremstilling af quinolinderivater
ES2083542T3 (es) Derivado del acido tienil-2-glicidico, su procedimiento de preparacion, y su utilizacion como intermediario de sintesis.
DK129578A (da) Fremgangsmaade til fremstilling af oximderivater af 3-acetoxymethyl-7-aminothiazolylacetamidocephalosporansyre
CN103360391B (zh) 阿哌沙班新晶型及其制备方法
DK1496865T3 (da) Fremgangsmåde til fremstilling af krystaller, ifölge denne opnåelige krystaller og deres anvendelse i farmaceutiske formuleringer
ATE209187T1 (de) Fluorinierte 2-nitroimidazole analoge zur detektion von hypoxischen tumorzellen
HUP0103202A2 (hu) Nimeszulidot tartalmazó topikális gyógyászati készítmények és eljárás az előállításukra
HUP0001522A2 (hu) Benzimidazol- és imidazo[4,5-c]piridin-származékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
ES2091958T3 (es) Quinolinas 2-sustituidas, procedimiento para su obtencion asi como su uso en medicamentos.
SE7901493L (sv) Nya amidderivat av 5-pyrimidin-karbonsyror och sett for deras framstellning och anvendning som lekemedel
DK246180A (da) Fremgangsmaade til fremstilling af paromomycinderivater
ES2056639T3 (es) Procedimiento para la transformacion del acido (benzoil-3 fenil)-2 propionico-r(-) en isomero s(+).
SE7811455L (sv) 2-imino-imidazolidin-derivat
DK0457090T3 (da) Fremgangsmåde til fremstilling af 3-amino-2-(het)-aroyl-acrylsyrederivater
DK1214321T3 (da) Proces til fremstilling af naphthyridin-3-carboxylsyre-derivater
BRPI9915669A (pt) modificação cristalina a do ácido 8-ciano-1-ciclopropil-7-(1s,6s-2,8-diazabiciclo-[4.3.0]nonan-8-il)-6-flúor-1,4-diidro-4-oxo-3-quinolinocarboxílico
DK1155018T3 (da) Krystalmodifikation C af 8-cyano-1-cyclopropyl-7-(1S, 6S-2,8- diazabicyclo [4.3.0]nonan-8-yl) -6-fluor-1,4-dihydro-4-oxo-3-quinolin-carboxylsyre
DK68978A (da) Fremgangsmaade til fremstilling af oximderivater af 3-thiadiazolythiomethyl-7-aminothiazolylacetamidocephalosporansyre
CN101228175A (zh) 具有肌肉松弛和抗炎活性的硫秋水仙苷类似物

Legal Events

Date Code Title Description
RDES Application refused

Effective date: 20180131